Amar Sawhney

Amar Sawhney


Amarpreet Sawhney is a serial entrepreneur, with a deep interest in medical devices. He is the Chairman and CEO OF Instylla Inc., which is developing new liquid embolics for tumour embolisation and hemostasis. He is also CEO of Rejoni Inc., which develops products to prevent adhesions following gynaecological interventions. Dr. Sawhney holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from IIT Delhi.

READ MORE
Carlos Peña

Carlos Peña


Carlos Peña, PhD, MS, is Chief Regulatory Officer and Chief Quality Officer, leading the newly-established Offices of Regulatory Services and Office of Quality Services at the Jacobs Institute. Carlos served 20+ years as a public servant in federal government. Before joining the JI, Carlos served as the Director of the Office of Neurological and Physical Medicine Devices at the Center for Devices and Radiological Health (CDRH) at the U.S. Food and Drug Administration (FDA), based in the Washington, DC area. Carlos holds a PhD in Neuroscience from Case Western Reserve University and a Masters in Comparative Physiology from the University of Connecticut.

READ MORE